TP53 mutations were detected in 54% of cases, with a higher frequency among patients with CK compared to those without CK (87% vs. 20%, respectively), and were also more commonly multi-hit among MDS-CK compared to MDS del(5q) (81% vs. 27%, respectively) [10]. This evidence concerns the gene TP53 and myelodysplastic syndrome.